You-bing Zheng
106 Zhongshan 2nd Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis.
Journal: Frontiers in immunology
Published: February 12, 2022
Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
Journal: Journal of cancer research and clinical oncology
Published: September 16, 2014
Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.
Journal: Oncology
Published: August 20, 2014
Clinical value of circulating tumor cells for the prognosis of postoperative transarterial chemoembolization therapy.
Journal: Medical oncology (Northwood, London, England)
Published: July 29, 2014
Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 25, 2014
The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.
Journal: Medical oncology (Northwood, London, England)
Published: June 20, 2014
Prognostic value of serum vascular endothelial growth factor receptor 2 response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Journal: Medical oncology (Northwood, London, England)
Published: December 19, 2013
The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 02, 2013
Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: August 20, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026